低位直肠癌患者行保肛根治术的临床疗效评价

The clinical efficacy of anal sphincter preservation for low rectal cancer

目的 评价低位直肠癌患者行保肛根治术的临床疗效.方法 回顾性分析2006-01～2012-12宝鸡市第三人民医院收治的32例采取保肛根治术的低位直肠癌患者的临床资料（观察组）,与同期采用腹会阴联合直肠癌根治术（Miles术）的32例患者（对照组）,进行术后Wexner、Vaizey、Pescatori和AMS量表进行肛门功能评估、并发症发生率和远期疗效观察.结果 观察组与对照组在并发症发生率方面无明显差异（P＞0.05）,且两组间1年和3年生存率比较也无明显差异（P＞0.05）;观察组与对照组采用Wexner、Vaizey、Pescatori、AMS四量表对肛门功能进行分析,结果显示观察组均优于对照组,差异有统计学意义（P＜0.05）.结论 低位直肠癌保肛根治术大大提高了直肠癌患者的保肛率,并保证了肛门功能,同时也确保了患者近、远期疗效.

Objective To evaluate the clinical efficacy of anal sphincter preservation for low rectal cancer. Methods From January 2006 to December 2012 in our hospital, the clinical data of 32 patients with low rectal cancer undergoing anal sphincter preservation （observation group） were analyzed retrospectively. At the same period,32 patients undergoing Miles operation were chosen as control group. All patients were evaluated with questionnaires, and the incidence of complication and long-term curative effect were compared. Results There was no significant difference between two groups in the incidence of complication, 1 - year and 3 - year survival rates （ all P 〉 0. 05 ）. Tlae scores of Wexner, gaizey ,Pescatori ,AMS questionnaires were lower in observation group than in control group（ P 〈 0. 05）. Conclusion The anal sphincter preservation can improve the rate of anal preservation in patients with low rectal cancer, keep the anal function, and have the good recent and long-term curative effects.